Which companies overlap with Instituto de Oftalmología Fundación Conde de Valenciana's portfolio?

Top competitors by shared drug class: Cardiol Therapeutics Inc., Direct Biologics, LLC.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/instituto-de-oftalmolog-a-fundaci-n-conde-de-valenciana.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Instituto de Oftalmología Fundación Conde de Valenciana — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Instituto de Oftalmología Fundación Conde de Valenciana pipeline: 5 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

5 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Area
Nepafenac and lubricant	Nepafenac and lubricant	marketed
Duosomal chemical peel application	Duosomal chemical peel application	marketed
Besifloxacin Ophthalmic	Besifloxacin Ophthalmic	marketed
Intralesional administration of 5-fluorouracil	Intralesional administration of 5-fluorouracil	marketed
Topical lyophilized exosomes application	Topical lyophilized exosomes application	marketed	Exosome therapy	Ophthalmology

Therapeutic area mix

Ophthalmology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Cardiol Therapeutics Inc. · 1 shared drug class
Direct Biologics, LLC · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Instituto de Oftalmología Fundación Conde de Valenciana:

Cite this brief

Drug Landscape (2026). Instituto de Oftalmología Fundación Conde de Valenciana — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/instituto-de-oftalmolog-a-fundaci-n-conde-de-valenciana. Accessed 2026-05-17.